KCM
NUVB icon

Kornitzer Capital Management’s Nuvation Bio NUVB Stock Holding History

Kornitzer Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$813K Sell
143,051
-4,824
-3% -$23.6K 0.02% 464
2026
Q1 		$634K Buy
+147,875
New +$824K 0.01% 447

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Kornitzer Capital Management's NUVB Position: Q2 2026 in Review

Kornitzer Capital Management reduced its Nuvation Bio (NUVB) stake by 3.3% in Q2 2026, selling an estimated $23.6K and leaving 143,051 shares worth $813K. The position accounts for 0.02% of the portfolio, ranked #464.

Kornitzer Capital Management first reported a position in NUVB in Q1 2026 and has held it in 2 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Kornitzer Capital Management held 143,051 shares of Nuvation Bio worth $813K as of Q2 2026.
  • Kornitzer Capital Management sold 4,824 Nuvation Bio shares in Q2 2026, an estimated $23.6K.
  • Nuvation Bio made up 0.02% of Kornitzer Capital Management's portfolio in Q2 2026, its #464 holding.
  • Kornitzer Capital Management first reported a position in Nuvation Bio in Q1 2026 and has held it in 2 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.